Last reviewed · How we verify

"Probiotics" and "Metronidazole"

Peking University Shenzhen Hospital · FDA-approved active Small molecule

"Probiotics" and "Metronidazole" is a Antibiotic + Probiotic combination Small molecule drug developed by Peking University Shenzhen Hospital. It is currently FDA-approved for Anaerobic bacterial infections (e.g., bacterial vaginosis, anaerobic infections of the gastrointestinal tract), Microbiota restoration and support during or after antibiotic therapy. Also known as: Umeta-Miyue, Lactobacillus rhamnosus GR-1 & Lactobacillus reuteri RC-14 and Metronidazole Suppositories.

Metronidazole kills anaerobic bacteria and certain parasites, while probiotics restore beneficial gut microbiota to support intestinal health and immune function.

Metronidazole kills anaerobic bacteria and certain parasites, while probiotics restore beneficial gut microbiota to support intestinal health and immune function. Used for Anaerobic bacterial infections (e.g., bacterial vaginosis, anaerobic infections of the gastrointestinal tract), Microbiota restoration and support during or after antibiotic therapy.

At a glance

Generic name"Probiotics" and "Metronidazole"
Also known asUmeta-Miyue, Lactobacillus rhamnosus GR-1 & Lactobacillus reuteri RC-14 and Metronidazole Suppositories
SponsorPeking University Shenzhen Hospital
Drug classAntibiotic + Probiotic combination
ModalitySmall molecule
Therapeutic areaGastroenterology / Infectious Disease
PhaseFDA-approved

Mechanism of action

Metronidazole is a nitroimidazole antibiotic that disrupts DNA in anaerobic microorganisms, making it effective against infections caused by anaerobic bacteria and protozoa. Probiotics introduce live beneficial bacteria (typically Lactobacillus or Bifidobacterium species) to restore normal gut flora balance, which may enhance barrier function, reduce pathogenic colonization, and support immune homeostasis. Together, this combination aims to treat infection while simultaneously restoring healthy microbiota.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about "Probiotics" and "Metronidazole"

What is "Probiotics" and "Metronidazole"?

"Probiotics" and "Metronidazole" is a Antibiotic + Probiotic combination drug developed by Peking University Shenzhen Hospital, indicated for Anaerobic bacterial infections (e.g., bacterial vaginosis, anaerobic infections of the gastrointestinal tract), Microbiota restoration and support during or after antibiotic therapy.

How does "Probiotics" and "Metronidazole" work?

Metronidazole kills anaerobic bacteria and certain parasites, while probiotics restore beneficial gut microbiota to support intestinal health and immune function.

What is "Probiotics" and "Metronidazole" used for?

"Probiotics" and "Metronidazole" is indicated for Anaerobic bacterial infections (e.g., bacterial vaginosis, anaerobic infections of the gastrointestinal tract), Microbiota restoration and support during or after antibiotic therapy.

Who makes "Probiotics" and "Metronidazole"?

"Probiotics" and "Metronidazole" is developed and marketed by Peking University Shenzhen Hospital (see full Peking University Shenzhen Hospital pipeline at /company/peking-university-shenzhen-hospital).

Is "Probiotics" and "Metronidazole" also known as anything else?

"Probiotics" and "Metronidazole" is also known as Umeta-Miyue, Lactobacillus rhamnosus GR-1 & Lactobacillus reuteri RC-14 and Metronidazole Suppositories.

What drug class is "Probiotics" and "Metronidazole" in?

"Probiotics" and "Metronidazole" belongs to the Antibiotic + Probiotic combination class. See all Antibiotic + Probiotic combination drugs at /class/antibiotic-probiotic-combination.

What development phase is "Probiotics" and "Metronidazole" in?

"Probiotics" and "Metronidazole" is FDA-approved (marketed).

What are the side effects of "Probiotics" and "Metronidazole"?

Common side effects of "Probiotics" and "Metronidazole" include Metallic taste, Nausea, Headache, Gastrointestinal upset (probiotics), Allergic reactions (rare).

Related